![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Via Surgical Secures $6M for FasTouch Deployable Suture Fixation System
Via Surgical Secures $6M for FasTouch Deployable Suture Fixation System
![](https://www.fdanews.com/ext/resources/test/Device_Images5/money_bundle.jpg?t=1439834546&width=430)
February 9, 2016
Via Surgical has landed $6 million for its FasTouch deployable suture fixation system, the company announced.
The investment — led by Benslie Investment Group — will support the increasing clinical demand for improved fixation through development and marketing efforts in 2016, Via said.
FasTouch is the first technology with the potential to provide a comprehensive fixation solution in hernia repair, according to the company. — Jonathon Shacat
Upcoming Events
-
21Oct